Stay updated on Safety of hESC-RPE in Stargardt's Clinical Trial
Sign up to get notified when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.

Latest updates to the Safety of hESC-RPE in Stargardt's Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check26 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

- Check40 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No other substantive changes to core content, pricing, stock, or time-related information were detected.SummaryDifference0.2%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to retinal disorders, specifically Stargardt disease and congenital diseases. Notably, previous mentions of age-related macular degeneration and specific location details have been removed.SummaryDifference3%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Safety of hESC-RPE in Stargardt's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.